New combo therapy aims to beat fibromyalgia pain
NCT ID NCT07382921
First seen Feb 03, 2026 · Last updated May 16, 2026 · Updated 15 times
Summary
This study tests whether adding tizanidine to the standard drug pregabalin can better relieve pain in people with fibromyalgia. Fibromyalgia causes widespread pain, fatigue, and emotional distress, and current treatments often provide only modest relief. The trial will enroll 164 adults aged 18-65 who have daily pain, and compare the combination therapy to pregabalin alone over 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital, Capital Medical University in Beijing
Beijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.